CNR1 and major depressive disorder: In humans, posttraumatic stress disorder or major depressive disorder is associated with reductions of the circulating levels of endocannabinoids [48, 66, 106], and a significant proportion of individuals using the CB1 antagonist rimonabant for weight loss developed indices of anxiety and depression and suicide and finally, withdrawal of the drug [16, 99].